2023 Q2 Form 10-Q Financial Statement

#000095017023016051 Filed on May 01, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q4
Revenue $758.9M $791.8M $788.5M
YoY Change 21.96% 55.45% 69.02%
Cost Of Revenue $488.1M $512.7M $515.8M
YoY Change 9.22% 33.78% 36.14%
Gross Profit $270.8M $279.1M $272.7M
YoY Change 54.44% 121.26% 211.27%
Gross Profit Margin 35.68% 35.25% 34.58%
Selling, General & Admin $33.26M $30.57M $34.58M
YoY Change 27.52% 11.31% 52.28%
% of Gross Profit 12.28% 10.95% 12.68%
Research & Development $0.00 $136.0K $250.0K
YoY Change -100.0% -44.49% 0.0%
% of Gross Profit 0.0% 0.05% 0.09%
Depreciation & Amortization $126.8M $128.2M $123.3M
YoY Change 4.33% 9.61% -70.01%
% of Gross Profit 46.83% 45.92% 45.22%
Operating Expenses $160.5M $30.57M $157.9M
YoY Change 515.42% 11.31% -63.63%
Operating Profit $110.3M $126.0M $114.7M
YoY Change 200.05% -767.14% -133.11%
Interest Expense -$8.526M $8.826M -$7.785M
YoY Change -180.0% -16.46% -26.25%
% of Operating Profit -7.73% 7.01% -6.78%
Other Income/Expense, Net $2.323M -$6.100M -$629.0K
YoY Change -117.74% -31.98% -43.59%
Pretax Income $98.38M $119.9M $108.4M
YoY Change 315.7% -530.4% -129.1%
Income Tax $13.77M $20.19M $8.294M
% Of Pretax Income 13.99% 16.84% 7.65%
Net Earnings $84.61M $99.68M $100.1M
YoY Change 286.61% -446.38% -127.66%
Net Earnings / Revenue 11.15% 12.59% 12.69%
Basic Earnings Per Share $0.41 $0.47
Diluted Earnings Per Share $0.40 $0.46 $0.46
COMMON SHARES
Basic Shares Outstanding 208.2M 213.7M 216.8M
Diluted Shares Outstanding 209.0M 215.9M

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $150.3M $157.2M $137.6M
YoY Change 665.37% 225.75% 17.04%
Cash & Equivalents $150.3M $157.2M $137.6M
Short-Term Investments
Other Short-Term Assets $91.95M $64.21M $67.91M
YoY Change 23.07% 4.06% 0.43%
Inventory $68.04M $65.28M $58.04M
Prepaid Expenses $22.49M $7.923M $11.96M
Receivables $491.0M $493.0M $565.5M
Other Receivables $0.00 $525.0K $399.0K
Total Short-Term Assets $801.3M $780.3M $829.4M
YoY Change 28.99% 46.42% 42.11%
LONG-TERM ASSETS
Property, Plant & Equipment $2.282B $2.253B $2.261B
YoY Change -0.31% -2.26% -3.05%
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $28.38M $10.53M $10.88M
YoY Change 149.45% -17.58% -1.57%
Total Long-Term Assets $2.316B $2.312B $2.314B
YoY Change -0.98% -1.87% -2.52%
TOTAL ASSETS
Total Short-Term Assets $801.3M $780.3M $829.4M
Total Long-Term Assets $2.316B $2.312B $2.314B
Total Assets $3.117B $3.092B $3.144B
YoY Change 5.31% 7.04% 6.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $245.6M $271.4M $237.1M
YoY Change -2.82% 31.26% 24.62%
Accrued Expenses $189.6M $204.0M $304.1M
YoY Change 0.2% 11.88% 27.52%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change
Total Short-Term Liabilities $454.3M $486.8M $551.0M
YoY Change 1.32% 22.88% 26.41%
LONG-TERM LIABILITIES
Long-Term Debt $822.4M $822.2M $830.9M
YoY Change -6.3% -3.56% -2.51%
Other Long-Term Liabilities $61.66M $44.58M $48.07M
YoY Change 478.18% 177.89% 274.25%
Total Long-Term Liabilities $884.1M $866.8M $879.0M
YoY Change -0.49% -0.21% 1.6%
TOTAL LIABILITIES
Total Short-Term Liabilities $454.3M $486.8M $551.0M
Total Long-Term Liabilities $884.1M $866.8M $879.0M
Total Liabilities $1.397B $1.419B $1.478B
YoY Change 0.95% 8.16% 9.64%
SHAREHOLDERS EQUITY
Retained Earnings $62.90M -$4.895M -$87.39M
YoY Change -128.24% -97.92% -55.93%
Common Stock $3.212B $3.205B $3.206B
YoY Change 0.54% 0.82% 0.99%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.555B $1.527B $1.453B
YoY Change 11.38% 11.27% 5.86%
Treasury Stock Shares $96.93M $94.39M $88.76M
Shareholders Equity $1.720B $1.673B $1.666B
YoY Change
Total Liabilities & Shareholders Equity $3.117B $3.092B $3.144B
YoY Change 5.31% 7.04% 6.29%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q4
OPERATING ACTIVITIES
Net Income $84.61M $99.68M $100.1M
YoY Change 286.61% -446.38% -127.66%
Depreciation, Depletion And Amortization $126.8M $128.2M $123.3M
YoY Change 4.33% 9.61% -70.01%
Cash From Operating Activities $162.9M $234.3M $302.9M
YoY Change 217.19% 595.93% 590.1%
INVESTING ACTIVITIES
Capital Expenditures $132.4M $117.6M $119.2M
YoY Change 37.38% 24.02% -257.97%
Acquisitions
YoY Change
Other Investing Activities $6.527M $1.256M $5.669M
YoY Change -43.46% -13.97% -60.94%
Cash From Investing Activities -$125.9M -$116.3M -$113.6M
YoY Change 48.38% 24.61% 86.28%
FINANCING ACTIVITIES
Cash Dividend Paid $16.92M
YoY Change 96.45%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -43.92M -98.34M -94.55M
YoY Change -1367.9% 1040.29% 65.71%
NET CHANGE
Cash From Operating Activities 162.9M 234.3M 302.9M
Cash From Investing Activities -125.9M -116.3M -113.6M
Cash From Financing Activities -43.92M -98.34M -94.55M
Net Change In Cash -6.930M 19.67M 94.82M
YoY Change -76.91% -128.39% -227.91%
FREE CASH FLOW
Cash From Operating Activities $162.9M $234.3M $302.9M
Capital Expenditures $132.4M $117.6M $119.2M
Free Cash Flow $30.46M $116.7M $183.7M
YoY Change -167.65% -290.91% 53.87%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000889900
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-39270
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Patterson-UTI Energy, Inc.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-2504748
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
10713 W. Sam Houston Pkwy N
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 800
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Houston
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
77064
CY2023Q1 dei City Area Code
CityAreaCode
281
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
765-7100
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $0.01 Par Value
CY2023Q1 dei Trading Symbol
TradingSymbol
PTEN
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
208247403
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
157218000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
137553000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2881000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2875000
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
493038000
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
565520000
CY2023Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
525000
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
399000
CY2023Q1 us-gaap Inventory Net
InventoryNet
65275000
CY2022Q4 us-gaap Inventory Net
InventoryNet
58038000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
64212000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
67909000
CY2023Q1 us-gaap Assets Current
AssetsCurrent
780268000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
829419000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2253468000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2260576000
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
19897000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
20841000
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5488000
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5845000
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
19123000
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
13051000
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10531000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
10881000
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3570000
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
3210000
CY2023Q1 us-gaap Assets
Assets
3092345000
CY2022Q4 us-gaap Assets
Assets
3143823000
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
271442000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
237056000
CY2023Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6290000
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
4644000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
204047000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
304143000
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5045000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5123000
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
486824000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
550966000
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
18390000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
19594000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5204000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5468000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
822196000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
830937000
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
47401000
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
28738000
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44577000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
48065000
CY2023Q1 us-gaap Liabilities
Liabilities
1419388000
CY2022Q4 us-gaap Liabilities
Liabilities
1478300000
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
302414610
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
302325853
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
208026771
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213567131
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
3024000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
3023000
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3202214000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
3202973000
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4895000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-87394000
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
94387839
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
88758722
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1527386000
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1453079000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1672957000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1665523000
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3092345000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3143823000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
791802000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
509375000
CY2023Q1 pten Depreciation Depletion Amortization And Impairment
DepreciationDepletionAmortizationAndImpairment
128180000
CY2022Q1 pten Depreciation Depletion Amortization And Impairment
DepreciationDepletionAmortizationAndImpairment
116938000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
30566000
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
27461000
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
1863000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
5566000
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1218000
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
665839000
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
528256000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
125963000
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-18881000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1240000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
15000
CY2023Q1 us-gaap Interest Expense
InterestExpense
8826000
CY2022Q1 us-gaap Interest Expense
InterestExpense
10565000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1486000
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1582000
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-6100000
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-8968000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
119863000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27849000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20185000
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
928000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
99678000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28777000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212089000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215267000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215866000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215267000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.08
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.04
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
99678000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28777000
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
0
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
115000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
99678000
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-28662000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1665523000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
99678000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-758000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.08
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
16916000
CY2023Q1 pten Dividend Equivalents
DividendEquivalents
263000
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
74307000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1672957000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1609487000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28777000
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
115000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4642000
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.04
CY2022Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
8611000
CY2022Q1 pten Dividend Equivalents
DividendEquivalents
144000
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
13000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1576699000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
99678000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-28777000
CY2023Q1 pten Depreciation Depletion Amortization And Impairment
DepreciationDepletionAmortizationAndImpairment
128180000
CY2022Q1 pten Depreciation Depletion Amortization And Impairment
DepreciationDepletionAmortizationAndImpairment
116938000
CY2023Q1 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
68000
CY2022Q1 us-gaap Exploration Abandonment And Impairment Expense
ExplorationAbandonmentAndImpairmentExpense
117000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
18303000
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
404000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
-758000
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4642000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-538000
CY2022Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1113000
CY2023Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1112000
CY2022Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
396000
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
400000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-72482000
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21252000
CY2023Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
1520000
CY2022Q1 us-gaap Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable
442000
CY2023Q1 us-gaap Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
3176000
CY2022Q1 us-gaap Increase Decrease In Inventories And Other Operating Assets
IncreaseDecreaseInInventoriesAndOtherOperatingAssets
-3179000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
24329000
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
13958000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-101080000
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-56199000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-5019000
CY2022Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
935000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
234349000
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33674000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
117601000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94828000
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1263000
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
3576000
CY2023Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
7000
CY2022Q1 us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
2116000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-116345000
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-93368000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
73586000
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
13000
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
16916000
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
8611000
CY2023Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
7837000
CY2022Q1 us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
0
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-98339000
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-8624000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-942000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
19665000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-69260000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
137553000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
117524000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157218000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48264000
CY2023Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
351000
CY2022Q1 us-gaap Interest Paid Capitalized
InterestPaidCapitalized
146000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
8871000
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
10574000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-335000
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-148000
CY2023Q1 pten Increase Decrease In Payables Related To Purchases Of Property And Equipment
IncreaseDecreaseInPayablesRelatedToPurchasesOfPropertyAndEquipment
10057000
CY2022Q1 pten Increase Decrease In Payables Related To Purchases Of Property And Equipment
IncreaseDecreaseInPayablesRelatedToPurchasesOfPropertyAndEquipment
2866000
CY2023Q1 pten Net Decrease Increase In Deposits On Equipment Purchases
NetDecreaseIncreaseInDepositsOnEquipmentPurchases
-6072000
CY2022Q1 pten Net Decrease Increase In Deposits On Equipment Purchases
NetDecreaseIncreaseInDepositsOnEquipmentPurchases
-6046000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1240000
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
15000
CY2023Q1 us-gaap Interest Expense
InterestExpense
8826000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
81300000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
890000000
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.26
CY2023Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1674000
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
28000
CY2023Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3020000
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2341000
CY2023Q1 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
60581000
CY2022Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
55669000
CY2023Q1 us-gaap Inventory Net
InventoryNet
65275000
CY2022Q4 us-gaap Inventory Net
InventoryNet
58038000
CY2023Q1 pten Workers Compensation Receivable
WorkersCompensationReceivable
35061000
CY2022Q4 pten Workers Compensation Receivable
WorkersCompensationReceivable
34632000
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7923000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11960000
CY2023Q1 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
21228000
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
21317000
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
64212000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
67909000
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8048251000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7986077000
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5794783000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5725501000
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2253468000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2260576000
CY2022Q1 us-gaap Interest Expense
InterestExpense
10565000
CY2023Q1 pten Accrued Salaries Wages Payroll Taxes And Benefits Current
AccruedSalariesWagesPayrollTaxesAndBenefitsCurrent
41917000
CY2022Q4 pten Accrued Salaries Wages Payroll Taxes And Benefits Current
AccruedSalariesWagesPayrollTaxesAndBenefitsCurrent
73308000
CY2023Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
66122000
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
67853000
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
13876000
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
10119000
CY2023Q1 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
3738000
CY2022Q4 us-gaap Accrued Insurance Current
AccruedInsuranceCurrent
3644000
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
10081000
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
10522000
CY2023Q1 us-gaap Deferred Revenue
DeferredRevenue
34058000
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
110215000
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
34255000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
28482000
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
204047000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
304143000
CY2023Q1 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
827400000
CY2022Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
836405000
CY2023Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5204000
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
5468000
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
822196000
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
830937000
CY2018Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1486000
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
0
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
827400000
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
827400000
CY2023Q1 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
65000000.0
CY2023Q1 us-gaap Purchase Commitment Remaining Minimum Amount Committed
PurchaseCommitmentRemainingMinimumAmountCommitted
129000000
CY2023Q1 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
17500000
CY2023Q1 us-gaap Unrecorded Unconditional Purchase Obligation Due In Remainder Of Fiscal Year
UnrecordedUnconditionalPurchaseObligationDueInRemainderOfFiscalYear
14500000
CY2023Q1 us-gaap Unrecorded Unconditional Purchase Obligation Balance On First Anniversary
UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary
3000000.0
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
88758722
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1453079000
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
94387839
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1527386000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1582000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2905150
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.19
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0
CY2023Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2905150
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
22.19
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2905150
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.19
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
119863000
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-27849000
CY2023Q1 pten Depreciation Depletion Amortization And Impairment
DepreciationDepletionAmortizationAndImpairment
128180000
CY2022Q1 pten Depreciation Depletion Amortization And Impairment
DepreciationDepletionAmortizationAndImpairment
116938000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
117601000
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
94828000
CY2023Q1 us-gaap Assets
Assets
3092345000
CY2022Q4 us-gaap Assets
Assets
3143823000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.168
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.033
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
99678000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-28777000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212089000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215267000
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.47
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
99678000
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-28777000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
212089000
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
215267000
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3777000
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215866000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
215267000
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.46
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2905000
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10739000
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
791802000
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
509375000

Files In Submission

Name View Source Status
0000950170-23-016051-index-headers.html Edgar Link pending
0000950170-23-016051-index.html Edgar Link pending
0000950170-23-016051.txt Edgar Link pending
0000950170-23-016051-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
pten-20230331.htm Edgar Link pending
pten-20230331.xsd Edgar Link pending
pten-ex31_1.htm Edgar Link pending
pten-ex31_2.htm Edgar Link pending
pten-20230331_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
pten-20230331_cal.xml Edgar Link unprocessable
pten-20230331_lab.xml Edgar Link unprocessable
pten-20230331_pre.xml Edgar Link unprocessable
pten-20230331_htm.xml Edgar Link completed
pten-ex32_1.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending